Valsartan blood pressure medication voluntarily recalled

On July 17, 2018, Prinston Pharmaceutical Inc., dba Solco Healthcare LLC, announced a voluntary recall of valsartan and valsartan-hydrochlorothiazide tablets from the market. The product is being recalled due to the detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).

We are notifying members

Claims data shows us that this voluntary recall impacts 1,793 members, all of which will receive letters alerting them to this recall in the next week. Additionally, all providers who had originally prescribed this medication will also receive a letter describing the recall.

In the patient letter, we encourage members to contact their physician or their pharmacist, and to review the FDA website or call Prinston Pharmaceutical Inc., dba Solco Healthcare LLC, at 888-679-5120 if they have additional questions.

Valsartan availability

  • Valsartan and valsartan-hydrochlorothiazide tablets manufactured by Prinston Pharmaceutical Inc., are no longer available and cannot be filled at any pharmacy.
  • Other valsartan and valsartan-hydrochlorothiazide products are still being manufactured; however, they may be available in a limited supply at some pharmacies.

Questions?

Learn more about the voluntary recall.